| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |